Knobbe Martens Olson & Bear LLP partner Brenden Gingrich, Ph.D. will be speaking at the Sino-American Biomedical & Pharmaceutical Professionals Association (SABPA) Innovations in Biologics Discovery and Development Forum on Saturday, March 23 at the Institute of the Americas on the University of California, San Diego (UCSD) campus.
Gingrich will be participating in a panel discussion on Biologics Development from 11:45 a.m. – 12:45 p.m. The event will bring together leaders in the academic and pharma/biotech industries to discuss current trends in biologics discovery and development, as well as challenges facing the field. The presentations will address new technologies in discovering novel biologic therapeutics including the use of unnatural amino acids, somatic hypermutation and directed molecular evolution as well as developing biologics delivery platform.
Knobbe Martens will also have an exhibit booth at the Forum where attendees can receive more information about the firm.
SABPA is a nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. The organization provides a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries, and provides opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations.
With over 275 lawyers and scientists nationwide, Knobbe Martens Olson & Bear LLP dedicates its practice to all aspects of intellectual property law including litigation. Consistently ranked among the top intellectual property firms worldwide, Knobbe Martens serves a diverse group of clients from multinational corporations to emerging businesses of all stages. Headquartered in Orange County, California, Knobbe Martens also has offices in San Diego, Los Angeles, Riverside, San Francisco, Silicon Valley, Seattle and Washington, D.C. More information about the firm can be found at www.knobbe.com.